Search Results 1-10 of 17573 for what is vedolizumab

  1. Vedolizumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Entyvio. Back to top. Description. Vedolizumab injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is a ...

  2. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    A healthcare professional will likely diagnose Crohn's disease only after ruling out other possible causes for symptoms. There is no single test to diagnose ...

  3. Ulcerative colitis - Diagnosis and treatment - Mayo Clinic

    Other types of tests can help rule out complications or other forms of inflammatory bowel disease, such as Crohn's disease. To help confirm a diagnosis of ...

  4. Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

    When used in a treat-to-target approach, therapies for mucosal healing may favorably modify the natural history of inflammatory bowel disease (IBD), ...

  5. Ulcerative colitis - Symptoms and causes - Mayo Clinic

    Ulcerative colitis is a type of inflammatory bowel disease (IBD) that causes inflammation and sores, called ulcers, in part of the digestive tract.

  6. Crohn's disease - Symptoms and causes - Mayo Clinic

    Crohn's disease is a type of inflammatory bowel disease (IBD) that causes swelling and irritation of the tissues, called inflammation, in the digestive ...

  7. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

    The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...

  8. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

    Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large ...

  9. A Study Comparing the Long Term Safety of Entyvio (Vedolizumab) to Other Biologic Agents in Patients with Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis or Crohn's ...

  10. Infliximab-dyyb (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Infliximab-dyyb injection is used to reduce the symptoms of moderate to severe active Crohn's disease and ulcerative colitis in adults and children who have ...